Navigating the ‘No AI’ Clause Minefield: Best Practices for Clinical Trial and Research Agreement Negotiations

As AI reshapes the world and R3 brings new rules about software in clinical trials, there has been a surge of “No AI” clauses in CDAs and clinical trial-related agreements. Many sites are finding themselves caught between these clauses and operational reality, which creates real friction in basic operational needs and  getting trials started. Join Florence Healthcare,  The Contract Network (TCN), WCG, and The Cleveland Clinic to explore how to navigate this minefield in contract negotiations.

In this session, industry experts will contrast the reality of AI in business operations and the life sciences field with the impossible mandate of “No AI” clauses that some sponsors and CROs are adding to contracts. We’ll explain the top 5 AI clause negotiation points, with real world examples, and share proven strategies for negotiating this term.

Learn actionable strategies for what to accept, reject and demand in these negotiations to keep your startup timelines on track.